Literature DB >> 21808165

Diagnosis and management of acute type A aortic dissection.

George Hines1, Cristina Dracea, Douglas S Katz.   

Abstract

Acute aortic dissection (AAD) is the most common aortic catastrophe. The mortality rate of type A dissection approaches 40% to 50% in 48 hours. Causes of death include rupture, aortic insufficiency, or malperfusion involving the coronary arteries, head vessels, visceral arteries, and lower extremities. Other acute aortic conditions can be confused with AAD. Emergent surgery is usually recommended, although there are some situations in which initial management of malperfusion or conservative therapy can be considered prior to proximal aortic repair. Various surgical techniques are employed to manage AAD. This article reviews the etiology, clinical presentations, and management of patients with type A AAD.

Entities:  

Mesh:

Year:  2011        PMID: 21808165     DOI: 10.1097/CRD.0b013e3182203ed9

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  4 in total

1.  Rare presentation of acute aortic dissection in a family doctor's office.

Authors:  Daniel L Pepe; Anna Pawelec-Brzychczy
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

2.  A case study of pulmonary embolism from the right atrial shunt after acute type a aortic dissection surgery.

Authors:  Wei J Yang; Qun J Duan; Hai F Cheng; Ai Q Dong
Journal:  J Cardiothorac Surg       Date:  2014-11-18       Impact factor: 1.637

3.  Medical management of acute type a aortic dissection in association with early open repair of acute limb ischemia may prevent aortic surgery.

Authors:  Michalis N Gionis; George Kaimasidis; Emmanouel Tavlas; Nikolaos Kontopodis; Marina Plataki; Alexandros Kafetzakis; Christos V Ioannou
Journal:  Am J Case Rep       Date:  2013-02-22

4.  Endovascular treatment of two pseudoaneurysms originating from the left ventricle.

Authors:  Wojciech Cwikiel; Inger Keussen; Ronny Gustafsson; Arash Mokhtari
Journal:  Cardiovasc Intervent Radiol       Date:  2013-01-19       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.